Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma
Salivary duct carcinoma (SDC) is an aggressive malignant tumor with a high mortality, which resembles high-grade breast ductal carcinoma in morphology. The parotid gland is the most common location. Its molecular genetic characteristics remain largely unknown. We have previously reported high incide...
Gespeichert in:
Veröffentlicht in: | BioMed research international 2014-01, Vol.2014 (2014), p.1-7 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7 |
---|---|
container_issue | 2014 |
container_start_page | 1 |
container_title | BioMed research international |
container_volume | 2014 |
creator | Qiu, Wanglong Tong, Guo-Xia Turk, Andrew T. Close, Lanny G. Caruana, Salvatore M. Su, Gloria H. |
description | Salivary duct carcinoma (SDC) is an aggressive malignant tumor with a high mortality, which resembles high-grade breast ductal carcinoma in morphology. The parotid gland is the most common location. Its molecular genetic characteristics remain largely unknown. We have previously reported high incidence of PIK3CA somatic mutations in head and neck squamous cell carcinoma, particularly in pharyngeal cancers. Here we examined the PIK3CA gene expression status and hotspot mutations in six cases of SDC by immunohistochemistry and genomic DNA sequencing. Immunohistochemistry showed that PIK3CA expression was elevated in all six patients with SDC. By DNA sequencing, two hotspot mutations of the PIK3CA gene, E545K (exon 9) and H1047R (exon 20), were identified in two of the six cases. Our results support that oncogenic PIK3CA is upregulated and frequently mutated in human SDC, adding evidence that PIK3CA oncogenic pathway is critical in the tumorigenesis of SDC, and may be a plausible drug target for this rare disease. |
doi_str_mv | 10.1155/2014/810487 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3910486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A427024545</galeid><sourcerecordid>A427024545</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-213a0636ab110095a6f80b5cc4f31b97ef853b46a0e0c17dd7227509552f933a3</originalsourceid><addsrcrecordid>eNqFkc1LHTEUxUOxqFhXXVcG3JSWp7n5msmm8Hi2VfrEQtt1uJPJPCMzic6Hxf--GcY-Wzdmk5D8crjnHELeAj0BkPKUURCnBVBR5K_IPuMgFgoE7GzPnO-Rw76_oWkVoKhWu2SPCZl-C7VP1lfBxo0L3mbfL77x1TK7HAccfAwZhio7e-g7txmb-caH7HxsMWQ_sPH32D1kZ6MdshV21ofY4hvyusamd4eP-wH59eXzz9X5Yn319WK1XC-s0HRYMOBIFVdYAlCqJaq6oKW0VtQcSp27upC8FAqpoxbyqsoZy2UCJas158gPyKdZ93YsW1dZF4YOG3Pb-TYNZSJ68_9L8NdmE-8N11NSKgm8fxTo4t3o-sG0vreuaTC4OPYGJBcFY0zRl1GhdQpcK57Q42foTRy7kJKYKCUAdAFP1AYbZ3yoYxrRTqJmKVhOUzdCJurjTNku9qmDeusOqJmaN1PzZm4-0Uf_BrJl__acgA8zcO1Dhb_9C2rvZtglxNW4hZPV5JX_AT7Buvo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1496411981</pqid></control><display><type>article</type><title>Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Qiu, Wanglong ; Tong, Guo-Xia ; Turk, Andrew T. ; Close, Lanny G. ; Caruana, Salvatore M. ; Su, Gloria H.</creator><contributor>Gabelli, Sandra B.</contributor><creatorcontrib>Qiu, Wanglong ; Tong, Guo-Xia ; Turk, Andrew T. ; Close, Lanny G. ; Caruana, Salvatore M. ; Su, Gloria H. ; Gabelli, Sandra B.</creatorcontrib><description>Salivary duct carcinoma (SDC) is an aggressive malignant tumor with a high mortality, which resembles high-grade breast ductal carcinoma in morphology. The parotid gland is the most common location. Its molecular genetic characteristics remain largely unknown. We have previously reported high incidence of PIK3CA somatic mutations in head and neck squamous cell carcinoma, particularly in pharyngeal cancers. Here we examined the PIK3CA gene expression status and hotspot mutations in six cases of SDC by immunohistochemistry and genomic DNA sequencing. Immunohistochemistry showed that PIK3CA expression was elevated in all six patients with SDC. By DNA sequencing, two hotspot mutations of the PIK3CA gene, E545K (exon 9) and H1047R (exon 20), were identified in two of the six cases. Our results support that oncogenic PIK3CA is upregulated and frequently mutated in human SDC, adding evidence that PIK3CA oncogenic pathway is critical in the tumorigenesis of SDC, and may be a plausible drug target for this rare disease.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2014/810487</identifier><identifier>PMID: 24511546</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Aged ; Cancer ; Cancer therapies ; Carcinoma ; Carcinoma - genetics ; Chemotherapy ; Class I Phosphatidylinositol 3-Kinases ; Deoxyribonucleic acid ; DNA ; Female ; Gene amplification ; Gene mutations ; Genetic aspects ; Health Insurance Portability & Accountability Act 1996-US ; Humans ; Identification and classification ; Kinases ; Male ; Medical prognosis ; Middle Aged ; Mortality ; Mutation ; Mutation - genetics ; Patients ; Phosphatidylinositol 3-Kinases - genetics ; Radiation therapy ; Salivary Gland Neoplasms - genetics ; Salivary gland tumors ; Studies ; Surgery ; Tumors</subject><ispartof>BioMed research international, 2014-01, Vol.2014 (2014), p.1-7</ispartof><rights>Copyright © 2014 Wanglong Qiu et al.</rights><rights>COPYRIGHT 2014 John Wiley & Sons, Inc.</rights><rights>Copyright © 2014 Wanglong Qiu et al. Wanglong Qiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 Wanglong Qiu et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-213a0636ab110095a6f80b5cc4f31b97ef853b46a0e0c17dd7227509552f933a3</citedby><cites>FETCH-LOGICAL-c490t-213a0636ab110095a6f80b5cc4f31b97ef853b46a0e0c17dd7227509552f933a3</cites><orcidid>0000-0003-2878-1251</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910486/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910486/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24511546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Gabelli, Sandra B.</contributor><creatorcontrib>Qiu, Wanglong</creatorcontrib><creatorcontrib>Tong, Guo-Xia</creatorcontrib><creatorcontrib>Turk, Andrew T.</creatorcontrib><creatorcontrib>Close, Lanny G.</creatorcontrib><creatorcontrib>Caruana, Salvatore M.</creatorcontrib><creatorcontrib>Su, Gloria H.</creatorcontrib><title>Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Salivary duct carcinoma (SDC) is an aggressive malignant tumor with a high mortality, which resembles high-grade breast ductal carcinoma in morphology. The parotid gland is the most common location. Its molecular genetic characteristics remain largely unknown. We have previously reported high incidence of PIK3CA somatic mutations in head and neck squamous cell carcinoma, particularly in pharyngeal cancers. Here we examined the PIK3CA gene expression status and hotspot mutations in six cases of SDC by immunohistochemistry and genomic DNA sequencing. Immunohistochemistry showed that PIK3CA expression was elevated in all six patients with SDC. By DNA sequencing, two hotspot mutations of the PIK3CA gene, E545K (exon 9) and H1047R (exon 20), were identified in two of the six cases. Our results support that oncogenic PIK3CA is upregulated and frequently mutated in human SDC, adding evidence that PIK3CA oncogenic pathway is critical in the tumorigenesis of SDC, and may be a plausible drug target for this rare disease.</description><subject>Aged</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoma</subject><subject>Carcinoma - genetics</subject><subject>Chemotherapy</subject><subject>Class I Phosphatidylinositol 3-Kinases</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Female</subject><subject>Gene amplification</subject><subject>Gene mutations</subject><subject>Genetic aspects</subject><subject>Health Insurance Portability & Accountability Act 1996-US</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Kinases</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Patients</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><subject>Radiation therapy</subject><subject>Salivary Gland Neoplasms - genetics</subject><subject>Salivary gland tumors</subject><subject>Studies</subject><subject>Surgery</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkc1LHTEUxUOxqFhXXVcG3JSWp7n5msmm8Hi2VfrEQtt1uJPJPCMzic6Hxf--GcY-Wzdmk5D8crjnHELeAj0BkPKUURCnBVBR5K_IPuMgFgoE7GzPnO-Rw76_oWkVoKhWu2SPCZl-C7VP1lfBxo0L3mbfL77x1TK7HAccfAwZhio7e-g7txmb-caH7HxsMWQ_sPH32D1kZ6MdshV21ofY4hvyusamd4eP-wH59eXzz9X5Yn319WK1XC-s0HRYMOBIFVdYAlCqJaq6oKW0VtQcSp27upC8FAqpoxbyqsoZy2UCJas158gPyKdZ93YsW1dZF4YOG3Pb-TYNZSJ68_9L8NdmE-8N11NSKgm8fxTo4t3o-sG0vreuaTC4OPYGJBcFY0zRl1GhdQpcK57Q42foTRy7kJKYKCUAdAFP1AYbZ3yoYxrRTqJmKVhOUzdCJurjTNku9qmDeusOqJmaN1PzZm4-0Uf_BrJl__acgA8zcO1Dhb_9C2rvZtglxNW4hZPV5JX_AT7Buvo</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Qiu, Wanglong</creator><creator>Tong, Guo-Xia</creator><creator>Turk, Andrew T.</creator><creator>Close, Lanny G.</creator><creator>Caruana, Salvatore M.</creator><creator>Su, Gloria H.</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TO</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2878-1251</orcidid></search><sort><creationdate>20140101</creationdate><title>Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma</title><author>Qiu, Wanglong ; Tong, Guo-Xia ; Turk, Andrew T. ; Close, Lanny G. ; Caruana, Salvatore M. ; Su, Gloria H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-213a0636ab110095a6f80b5cc4f31b97ef853b46a0e0c17dd7227509552f933a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoma</topic><topic>Carcinoma - genetics</topic><topic>Chemotherapy</topic><topic>Class I Phosphatidylinositol 3-Kinases</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Female</topic><topic>Gene amplification</topic><topic>Gene mutations</topic><topic>Genetic aspects</topic><topic>Health Insurance Portability & Accountability Act 1996-US</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Kinases</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Patients</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><topic>Radiation therapy</topic><topic>Salivary Gland Neoplasms - genetics</topic><topic>Salivary gland tumors</topic><topic>Studies</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qiu, Wanglong</creatorcontrib><creatorcontrib>Tong, Guo-Xia</creatorcontrib><creatorcontrib>Turk, Andrew T.</creatorcontrib><creatorcontrib>Close, Lanny G.</creatorcontrib><creatorcontrib>Caruana, Salvatore M.</creatorcontrib><creatorcontrib>Su, Gloria H.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qiu, Wanglong</au><au>Tong, Guo-Xia</au><au>Turk, Andrew T.</au><au>Close, Lanny G.</au><au>Caruana, Salvatore M.</au><au>Su, Gloria H.</au><au>Gabelli, Sandra B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Salivary duct carcinoma (SDC) is an aggressive malignant tumor with a high mortality, which resembles high-grade breast ductal carcinoma in morphology. The parotid gland is the most common location. Its molecular genetic characteristics remain largely unknown. We have previously reported high incidence of PIK3CA somatic mutations in head and neck squamous cell carcinoma, particularly in pharyngeal cancers. Here we examined the PIK3CA gene expression status and hotspot mutations in six cases of SDC by immunohistochemistry and genomic DNA sequencing. Immunohistochemistry showed that PIK3CA expression was elevated in all six patients with SDC. By DNA sequencing, two hotspot mutations of the PIK3CA gene, E545K (exon 9) and H1047R (exon 20), were identified in two of the six cases. Our results support that oncogenic PIK3CA is upregulated and frequently mutated in human SDC, adding evidence that PIK3CA oncogenic pathway is critical in the tumorigenesis of SDC, and may be a plausible drug target for this rare disease.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>24511546</pmid><doi>10.1155/2014/810487</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2878-1251</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2314-6133 |
ispartof | BioMed research international, 2014-01, Vol.2014 (2014), p.1-7 |
issn | 2314-6133 2314-6141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3910486 |
source | MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; PubMed Central; Alma/SFX Local Collection |
subjects | Aged Cancer Cancer therapies Carcinoma Carcinoma - genetics Chemotherapy Class I Phosphatidylinositol 3-Kinases Deoxyribonucleic acid DNA Female Gene amplification Gene mutations Genetic aspects Health Insurance Portability & Accountability Act 1996-US Humans Identification and classification Kinases Male Medical prognosis Middle Aged Mortality Mutation Mutation - genetics Patients Phosphatidylinositol 3-Kinases - genetics Radiation therapy Salivary Gland Neoplasms - genetics Salivary gland tumors Studies Surgery Tumors |
title | Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oncogenic%20PIK3CA%20Mutation%20and%20Dysregulation%20in%20Human%20Salivary%20Duct%20Carcinoma&rft.jtitle=BioMed%20research%20international&rft.au=Qiu,%20Wanglong&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2014/810487&rft_dat=%3Cgale_pubme%3EA427024545%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1496411981&rft_id=info:pmid/24511546&rft_galeid=A427024545&rfr_iscdi=true |